Patente Estadounidense para nuestra Terapia

Terapia: Publicación de la concesión de Patente en EE.UU. El 14 de febrero de 2017 la Oficina de Patentes y Marcas Estadounidense publicó la concesión de la Patente de nuestra terapia con el número 9,567,384 por “Fosforilación en los residuos THR-248 y/o diana terapéutica en procesos patológicos que cursan por poliploidía…

Utilizamos cookies para optimizar nuestro sitio web y nuestro servicio.

Funcional Siempre activo

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferencias

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Estadísticas

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Actualidad

Patente Estadounidense para nuestra Terapia